NCT06153537 - A Research Study in Saudi Arabia to Understand How the Dose Check App Used With Tresiba Treatment Helps to Control Blood Sugar Level | Biotech Hunter

Enrollment

179

Participants

Timeline

Start Date

November 29, 2023

Primary Completion Date

March 24, 2025

Study Completion Date

March 24, 2025

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG

Insulin degludec

Participants will be treated with commercially available insulin degludec used with Dose Check app according to local label and routine clinical practice at the discretion of the treating physician.

Trial Locations (12)

12231

King Fahd Medical City, Riyadh, KSA, Riyadh

12474

Al Hammadi, Riyadh

12987

Dr. Sulaiman Al Habib Medical Group- Swedi, Riyadh

21231

Saudi airlines Medical Services, Jeddah

22141

Almoosa Specialist Hospital, Ihsaa

23521

Saudi German Hospital, Jeddah

34234

Al Mowasat Khobar, Khobar

34423

Sulaiman Al Habib- Al Khobar, Khobar

34445

King Fahad Hospital of the University, Khobar

51431

Dr. Sulaiman Al Habib- Al Qassim, Buraidah

62451

Saudi German Hospital, Khamis Mushait

Unknown

My clinic, Jeddah